8-K: Nuwellis Announces 1-for-35 Reverse Stock Split

Nuwellis, Inc. has announced a 1-for-35 reverse stock split of its common stock, effective June 27, 2024, to be traded on a split-adjusted basis starting June 28, 2024.

Summary

• Nuwellis, Inc. has implemented a 1-for-35 reverse stock split of its common stock.
• The reverse stock split was approved by stockholders at the annual meeting on June 6, 2024.
• The Board of Directors approved the specific 1-for-35 ratio on June 18, 2024.
• The reverse stock split will be effective as of 5:00 p.m. Eastern Time on June 27, 2024.
• Trading on a split-adjusted basis will begin on June 28, 2024.
• Every 35 shares of common stock will be combined into one share.
• Fractional shares resulting from the split will be rounded down, and shareholders will receive cash equal to the market value of the fractional share.
• The number of authorized shares remains at 100 million.
• The company's common stock will continue to trade on the Nasdaq Capital Market under the symbol NUWE.
• The new CUSIP number for the common stock is 67113Y603.

Sentiment

Score: 5

Explanation: The document is neutral in sentiment as it primarily announces a reverse stock split, which is a procedural action. While reverse stock splits can sometimes be viewed negatively, the document itself is factual and does not express any positive or negative outlook.

Positives

• The reverse stock split was approved by shareholders, indicating support for the measure.
• The company has provided clear communication regarding the reverse stock split and its implications.

Risks

• Reverse stock splits are often undertaken by companies with declining share prices, which may negatively impact investor sentiment.
• The reduction in the number of outstanding shares may not necessarily improve the company's underlying financial performance.

Management Comments

• The company announced the reverse stock split to be effective on June 27, 2024.

Industry Context

Reverse stock splits are a common corporate action, often used by companies to increase their stock price to meet minimum listing requirements or to make their stock more attractive to institutional investors. This action is not uncommon in the medical technology sector.

Comparison to Industry Standards

• Reverse stock splits are a relatively common practice for companies listed on the Nasdaq Capital Market that are facing low share prices.
• Other companies in the medical technology sector have also used reverse stock splits to maintain their listing or improve their stock price, such as Xtant Medical Holdings, Inc. which recently completed a 1-for-15 reverse stock split.
• The 1-for-35 ratio is within the range of reverse stock splits seen in the industry, which can vary from 1-for-2 to 1-for-100.

Stakeholder Impact

• Shareholders will have their number of shares reduced, but the value of their holdings should remain the same immediately after the split.
• Shareholders will receive cash for any fractional shares resulting from the split.
• The reverse stock split may impact the perceived value of the company by investors.

Next Steps

• The company's common stock will begin trading on a split-adjusted basis on June 28, 2024.
• Equiniti Trust Company, LLC will act as the exchange agent for the reverse stock split.

Key Dates

Keywords

reverse stock split, common stock, NUWE, Nasdaq, shareholders, stock split, equity